205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.23%
Positive revenue growth while QCOM is negative. John Neff might see a notable competitive edge here.
5.71%
Positive gross profit growth while QCOM is negative. John Neff would see a clear operational edge over the competitor.
0.51%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
6.95%
Positive operating income growth while QCOM is negative. John Neff might view this as a competitive edge in operations.
3.85%
Positive net income growth while QCOM is negative. John Neff might see a big relative performance advantage.
3.83%
Positive EPS growth while QCOM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
3.89%
Positive diluted EPS growth while QCOM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.33%
Share count expansion well above QCOM's 0.35%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.32%
Diluted share reduction more than 1.5x QCOM's 0.70%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.01%
Dividend reduction while QCOM stands at 0.33%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-12.94%
Negative OCF growth while QCOM is at 82.37%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-19.39%
Negative FCF growth while QCOM is at 94.26%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
60.04%
10Y revenue/share CAGR under 50% of QCOM's 252.03%. Michael Burry would suspect a lasting competitive disadvantage.
55.67%
5Y revenue/share CAGR at 50-75% of QCOM's 88.87%. Martin Whitman would worry about a lagging mid-term growth trajectory.
20.69%
3Y revenue/share CAGR under 50% of QCOM's 76.76%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
353.80%
10Y OCF/share CAGR under 50% of QCOM's 9366.90%. Michael Burry would worry about a persistent underperformance in cash creation.
269.23%
5Y OCF/share CAGR above 1.5x QCOM's 53.54%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
77.37%
3Y OCF/share CAGR at 50-75% of QCOM's 134.70%. Martin Whitman would suspect weaker recent execution or product competitiveness.
233.16%
Net income/share CAGR 1.25-1.5x QCOM's 200.31%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
169.17%
5Y net income/share CAGR 1.25-1.5x QCOM's 117.07%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
36.82%
Below 50% of QCOM's 153.71%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
21.69%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
13.46%
Positive 5Y equity/share CAGR while QCOM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1.85%
Positive short-term equity growth while QCOM is negative. John Neff sees a strong advantage in near-term net worth buildup.
677.64%
10Y dividend/share CAGR above 1.5x QCOM's 242.29%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
167.94%
5Y dividend/share CAGR above 1.5x QCOM's 36.52%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.02%
3Y dividend/share CAGR above 1.5x QCOM's 14.04%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
12.02%
AR growth well above QCOM's 3.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.32%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.49%
Asset growth well under 50% of QCOM's 5.30%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
10.30%
Under 50% of QCOM's 21.01%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-12.21%
We’re deleveraging while QCOM stands at 0.03%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.52%
Our R&D shrinks while QCOM invests at 4.42%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.78%
SG&A growth well above QCOM's 2.90%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.